CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE

Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMOLIGA, JOHN, LORENZ, JON, CERRETA, MICHAEL, BUSACCA, CARL A, VARSOLONA, RICHARD, VITOUS, JANA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SMOLIGA, JOHN
LORENZ, JON
CERRETA, MICHAEL
BUSACCA, CARL A
VARSOLONA, RICHARD
VITOUS, JANA
description Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}éthyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazépin-6-one.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005097796A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005097796A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005097796A33</originalsourceid><addsrcrecordid>eNqNjL0KglAYQF0aonoHocECP_DfbDO94gX1MzXyJiIStylKsE3ae-ykeoCmc4bDmQovL2N54UYRTYgYYBbnIgaiKasq-DRkfoYwKilCFoEJ8Vc2MGgwrFTAkvoIBuwPNMFxwaI1luz5qZ5gheMjZdnYVLqswW6rSbIuAakrVTZqn7onktIELMCEzIXJpb32fPHjTFgGpPBC4N294X3XnvmNP5ojaopiKo5tO5ar6_9Vb-lrPrM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE</title><source>esp@cenet</source><creator>SMOLIGA, JOHN ; LORENZ, JON ; CERRETA, MICHAEL ; BUSACCA, CARL A ; VARSOLONA, RICHARD ; VITOUS, JANA</creator><creatorcontrib>SMOLIGA, JOHN ; LORENZ, JON ; CERRETA, MICHAEL ; BUSACCA, CARL A ; VARSOLONA, RICHARD ; VITOUS, JANA</creatorcontrib><description>Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}éthyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazépin-6-one.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060105&amp;DB=EPODOC&amp;CC=WO&amp;NR=2005097796A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060105&amp;DB=EPODOC&amp;CC=WO&amp;NR=2005097796A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMOLIGA, JOHN</creatorcontrib><creatorcontrib>LORENZ, JON</creatorcontrib><creatorcontrib>CERRETA, MICHAEL</creatorcontrib><creatorcontrib>BUSACCA, CARL A</creatorcontrib><creatorcontrib>VARSOLONA, RICHARD</creatorcontrib><creatorcontrib>VITOUS, JANA</creatorcontrib><title>CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE</title><description>Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}éthyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazépin-6-one.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjL0KglAYQF0aonoHocECP_DfbDO94gX1MzXyJiIStylKsE3ae-ykeoCmc4bDmQovL2N54UYRTYgYYBbnIgaiKasq-DRkfoYwKilCFoEJ8Vc2MGgwrFTAkvoIBuwPNMFxwaI1luz5qZ5gheMjZdnYVLqswW6rSbIuAakrVTZqn7onktIELMCEzIXJpb32fPHjTFgGpPBC4N294X3XnvmNP5ojaopiKo5tO5ar6_9Vb-lrPrM</recordid><startdate>20060105</startdate><enddate>20060105</enddate><creator>SMOLIGA, JOHN</creator><creator>LORENZ, JON</creator><creator>CERRETA, MICHAEL</creator><creator>BUSACCA, CARL A</creator><creator>VARSOLONA, RICHARD</creator><creator>VITOUS, JANA</creator><scope>EVB</scope></search><sort><creationdate>20060105</creationdate><title>CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE</title><author>SMOLIGA, JOHN ; LORENZ, JON ; CERRETA, MICHAEL ; BUSACCA, CARL A ; VARSOLONA, RICHARD ; VITOUS, JANA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005097796A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SMOLIGA, JOHN</creatorcontrib><creatorcontrib>LORENZ, JON</creatorcontrib><creatorcontrib>CERRETA, MICHAEL</creatorcontrib><creatorcontrib>BUSACCA, CARL A</creatorcontrib><creatorcontrib>VARSOLONA, RICHARD</creatorcontrib><creatorcontrib>VITOUS, JANA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMOLIGA, JOHN</au><au>LORENZ, JON</au><au>CERRETA, MICHAEL</au><au>BUSACCA, CARL A</au><au>VARSOLONA, RICHARD</au><au>VITOUS, JANA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE</title><date>2006-01-05</date><risdate>2006</risdate><abstract>Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-3-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. L'invention concerne des formes cristallines dihydrates et anhydres de 5,11-dihydro-11-éthyl-5-méthyl-8-{2-{(1-oxydo-4-quinolinyl)oxy}éthyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazépin-6-one.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2005097796A3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title CRYSTALLINE FORMS OF 5,11-DIHYDRO-11-ETHYL-5-METHYL-8-{2-{(1-OXIDO-4-QUINOLINYL)OXY}ETHYL}-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T12%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMOLIGA,%20JOHN&rft.date=2006-01-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005097796A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true